ISTA Pharmaceuticals istavision.com


Public lists: Pharma Startups (4740)

ISTA Pharmaceuticals develops ophthalmic pharmaceuticals.

ISTA Pharmaceuticals develops ophthalmic pharmaceuticals.

Company (Acquired)

Phone: 949-788-6000

Fax:

15295 Alton Parkway

Irvine, 92618
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
ISTA Pharmaceuticals $287.2M Mar 27, 2012
See all 18 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related ISTA Pharmaceuticals Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 20 investors

Competitors

Company Status Description Investors

Solasia Pharma

Tokyo, Japan
IPO / Went publicSolasia Pharma, formerly known as JapanBridge, expedites patient access to unique oncology therapies through aggressive development and specialized commercialization throughout Japan, China and other Asian countries. Solasia has Asian rights to Sancuso (extended release granisetron transdermal patch) from ProStrakan Group plc and an exclusive license to ZIOPHARM's SP-02 / darinaparsin, in major Asian countries. Solasia is currently conducting a Phase 1 study of darinaparsin in PTCL in Japan and ...Show allLogin to see details

Ribozyme Pharmaceuticals

Folsom, California, United States
Alive / ActiveRibozyme Pharmaceuticals offers RNA-based pharmaceuticals for human diseaseLogin to see details
See all 18 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Ophthalmic formulations and uses thereof Jun 07, 2005 Feb 12, 2013 Patent